Ocuphire Pharma, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Ocuphire Pharma, Inc.
CIK #0001228627, 0001738266
EDGAR Form CIK 2011 - 2025
10-K [0001228627]
10-Q [0001228627]
3 [0001228627]
4 [0001228627]
5 [0001228627]
8-K [0001228627]
D [0001228627]
SC 13D [0001228627]
SC 13G [0001228627]
D [0001738266]
Form 13D/13G Filer Form 13D/13G Subject Filed
BIOS Fund III LP Opus Genetics Inc [2025-08-11]
Nantahala Capital Management LLC Opus Genetics Inc [2025-05-15]
Perceptive Advisors LLC Opus Genetics Inc [2025-03-31]
Foundation Fighting Blindness Retinal Degeneration Fund Opus Genetics Inc [2024-10-29]
Richmond Brothers Inc Ocuphire Pharma Inc [2022-05-17]
Apexian Pharmaceuticals Inc Ocuphire Pharma Inc [2021-03-26]
Sooch Mina Ocuphire Pharma Inc [2021-03-17]
Richmond Brothers Inc Ocuphire Pharma Inc [2020-11-16]
Altium Capital Management LP Ocuphire Pharma Inc [2020-11-16]
Empery Asset Management LP Ocuphire Pharma Inc [2020-11-12]
View All
Form 3/4/5 Subject 2011 - 2025
Opus Genetics, Inc.
Foundation Fighting Blindness, Inc.
Foundation Fighting Blindness Retinal Degeneration Fund
Graves Adrienne L
Bennett Jean
Ainsworth Sean
Rodgers Richard J
Manuso James S J
Gallagher Cam
Benton Susan
View All
Terms | Privacy | Guide
tony@aum13f.com